Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CHINA LIFE, Under Selling Pressure Post-results, Sags 5%+
Recommend 8 Positive 10 Negative 7 |
||||
|
||||
|
CHINA LIFE (02628.HK) charted a 44.1% surge in net profit in 2025, yet its stock price came under pressure this morning (26th), opening 0.51% lower. With expanded decline, the stock bottomed at HKD25.9, marking a more than four-month low. It last stood at HKD25.92, down 5.26%, with a turnover of 22.2669 million shares, involving HKD585 million. Last year, China Life's revenue added by 16.5% YoY to RMB616.065 billion, and net profit grew 44.1% YoY to RMB154.078 billion, with an EPS of RMB5.45. The company proposed a final dividend of RMB6.18 per 10 shares, with a total annual dividend of RMB8.56 per 10 shares, bringing the total dividend distribution to RMB24.195 billion, up 31.7% YoY. UBS stated that China Life's 2025 results met expectations, with robust NBV growth, and cut the target price from HKD42 to HKD40, maintaining a Buy rating. Citi commented that China Life's 2025 results were strong, with NBV growing 36% YoY, largely in line with the broker's expectations. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
